Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells.
J Gen Virol
; 102(1)2021 01.
Article
in En
| MEDLINE
| ID: mdl-33048041
Key words
Full text:
1
Database:
MEDLINE
Main subject:
CD4-Positive T-Lymphocytes
/
HIV-1
/
Virus Latency
/
CCR5 Receptor Antagonists
/
Maraviroc
Type of study:
Prognostic_studies
Limits:
Aged
/
Aged80
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2021
Type:
Article